Prevalence and Clinical Features of Idiopathic Parkinson's Disease in Western Turkey

Basit Öğe Kaydı
dc.authoridDagdeviren, Hamdi Nezih/0000-0001-5428-4377
dc.authorwosidDagdeviren, Hamdi Nezih/AAA-3946-2020
dc.contributor.authorGuler, Sibel
dc.contributor.authorCaylan, Ayse
dc.contributor.authorTuran, Nesrin
dc.contributor.authorDagdeviren, Nezih
dc.date.accessioned2024-06-12T11:03:39Z
dc.date.available2024-06-12T11:03:39Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractIntroduction: We aimed to determine the prevalence and risk factors of idiopathic Parkinson's disease (IPD) in Western Turkey, which encompasses Edirne and its surrounding districts. Methods: In this study, 9887 individuals, able to communicate and agreed to participate in the study, were evaluated. The data was obtained by answering a face-to-face questionnaire consisting of 53 questions from volunteers living at 30 randomly selected family health centers in Edirne and its counties. The questionnaire included demographic information, questions to evaluate potential concomitant conditions, and questions regarding the symptomatology used in IPD diagnosis. Following the questionnaire, it was planned to determine the degree of IPD with the Unified Parkinson's Disease Rating Scale (UPDRS) and the Hoehn and Yahr scale (HY) clinical rating scale in patients diagnosed with IPD to assess disease severity in patients diagnosed with IPD Results: Of the 9887 individuals, 118 were diagnosed with IPD according to the questionnaire results from Edirne and its districts, and the prevalence of IPD was 1.2%. Approximately, 58.4% of the patients with IPD were male and 41.6% were female, which was not significantly different (p=0.214). Non-motor symptoms such as difficulty urinating, anxiety, depression, fatigue, REM sleep behavior disorder, and difficulty falling asleep or staying asleep were also examined in patients diagnosed with IPD. Depression was identified in 45.7% of the cases, while the control group was 4.3% (p=0.001). Fatigue was identified in 46.8% of the cases and control group was 3.5% (p=0.002). Conclusions: IPD prevalence studies will increase the awareness in the community and provide early diagnosis and treatment as well as serve as a basis to increased life expectancy, reduce morbidity, and improve life quality.en_US
dc.identifier.doi10.29399/npa.27486
dc.identifier.endpage104en_US
dc.identifier.issn1300-0667
dc.identifier.issn1309-4866
dc.identifier.issue2en_US
dc.identifier.pmid35685054en_US
dc.identifier.scopus2-s2.0-85131230165en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage98en_US
dc.identifier.trdizinid518676en_US
dc.identifier.urihttps://doi.org/10.29399/npa.27486
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/518676
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21744
dc.identifier.volume59en_US
dc.identifier.wosWOS:000799769200004en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Neuropsychiatry Assoc-Turk Noropsikiyatri Dernegien_US
dc.relation.ispartofNoropsikiyatri Arsivi-Archives Of Neuropsychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIdiopathic Parkinson's Diseaseen_US
dc.subjectPrevalenceen_US
dc.subjectEdirneen_US
dc.subjectNon-Motor Symptomsen_US
dc.subjectConcomitant Diseasesen_US
dc.subjectPopulationen_US
dc.subjectDiagnosisen_US
dc.subjectEpidemiologyen_US
dc.subjectInventoryen_US
dc.titlePrevalence and Clinical Features of Idiopathic Parkinson's Disease in Western Turkeyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu